Xinling Wang
Key Laboratory Of Medical Molecular Virology
Shanghai, China
Shanghai, China
Last Updated: 09/26/2026
Save publications for later
Sign Up
Not sure about your diagnosis?
Check Your Symptoms
Found 36 publications
Predicted early fusion intermediates in the spike of ACE2-utilising bat coronavirus unveil broad-spectrum antiviral mechanisms.
Journal: Clinical and translational medicine
Published: August 08, 2025
Precision-engineered STING agonist nanoparticles enable coordinated mucosal-systemic immunity for durable pan-β-coronavirus protection.
Journal: Nature nanotechnology
Published: August 05, 2025
Antisera and antivirals targeting the conserved domains in SARS-CoV-2 S2 subunit are effective against ACE2-using MERSr-CoVs with spillover potential.
Journal: Virologica Sinica
Published: June 28, 2025
MERS-related coronavirus circulating in pangolins exhibits strong fusogenicity in human cells and high sensitivity to fusion inhibitors.
Journal: Cell reports. Medicine
Published: February 20, 2025
Alpaca-derived nanobody targeting the hydrophobic pocket of the HIV-1 gp41 NHR broadly neutralizes HIV-1 by blocking six-helix bundle formation.
Journal: Current research in microbial sciences
Published: August 23, 2024
Early fusion intermediate of ACE2-using coronavirus spike acting as an antiviral target.
Journal: Cell
Published: April 30, 2024
Strong cross immune responses against sarbecoviruses but not merbecoviruses in SARS-CoV-2 BA.5/BF.7-infected individuals with or without inactivated COVID-19 vaccination.
Journal: The Journal of infection
Published: February 29, 2024
SARS-CoV-2 evolution from the BA.2.86 to JN.1 variants: unexpected consequences.
Journal: Trends in immunology
Published: January 10, 2024
SARS-CoV-2 Omicron subvariant BA.2.86: limited potential for global spread.
Journal: Signal transduction and targeted therapy
Published: October 15, 2023
An engineered recombinant protein containing three structural domains in SARS-CoV-2 S2 protein has potential to act as a pan-human coronavirus entry inhibitor or vaccine antigen.
Journal: Emerging microbes & infections
Published: August 03, 2023
Last Updated: 09/26/2026